YRI – María Pérez Lanzón

YRI – Candela Cives-Losada

STSM – Ainhoa Villoria

STSM - Katarina Nikolic

"This collaboration has shown that integrating machine learning with experimental validation is not only feasible within the scope of a COST STSM — it is a highly effective strategy for accelerating early-stage drug discovery."

In the COST Action Short-Term Scientific Mission, our team took drug discovery from machine learning models all the way to biological validation — identifying promising novel inhibitors ready for experimental testing.

Full Success Story